40例肝硬化合并难治性肝腹水的临床治疗观察

目的：探讨肝硬化合并难治性肝腹水的临床疗效。方法：将2000年1月～2009年6月我院诊治的40例肝硬化难治性腹水患者随机分为基础治疗组（20例,采用常规治疗）和腹水超滤浓缩回输治疗组（20例,采用常规治疗联合腹水超滤浓缩回输）,观察两组临床疗效。结果：腹水超滤浓缩回输治疗组总有效率达90%,基础治疗组总有效率达70%,两组总有效率比较,有显著性差异（P〈0.05）。结论：应用腹水超滤浓缩回输治疗临床疗效确切、操作简单、副作用少,且能够迅速减轻患者痛苦,提高患者的生活质量,为治疗难治性腹水的最佳方法。

Clinical observation of liver cirrhosis with refractory ascites in 40 cases

Objective：To evaluate the efficacy of liver cirrhosis with refractory ascites.Methods：From January 2000 to June 2009 in our hospital,40 cases of cirrhosis with refractory ascites were randomly divided into treatment group（20 patients,with conventional therapy） and ultrafiltration of ascites reinfusion group（20 patients,treated with conventional therapy combined with ascites reinfusion）,the clinical efficacy of the two groups were compared.Results：The total effective rate in the ultrafiltration of ascites reinfusion was 90%,the treatment group was 70%,there was a significant difference between two groups（P〈0.05）.Conclusion：The application with ascites reinfusion therapy,clinical curative effect is sure,simple operation,less side effects and can be achieved quickly to reduce the suffering of patients and improve the life quality of patients for the treatment of refractory ascites in the best way.